Progression of whole brain and gray matter atrophy in relapsing MS despite treatment with natalizumab

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: e96ea6ecd3cd5ffbe55e95b3edcdb096a8e994dc
First added on: Feb 08, 2025